Mapping Canadian Data Assets to Generate Real-World Evidence: Lessons Learned from Canadian Real-World Evidence for Value of Cancer Drugs (CanREValue) Collaboration’s RWE Data Working Group

Canadian provinces routinely collect patient-level data for administrative purposes. These real-world data (RWD) can be used to generate real-world evidence (RWE) to inform clinical care and healthcare policy. The CanREValue Collaboration is developing a framework for the use of RWE in cancer drug f...

Descripción completa

Detalles Bibliográficos
Autores principales: Dai, Wei Fang, de Oliveira, Claire, Blommaert, Scott, Pataky, Reka E., Tran, David, Aurangzeb, Zeb, Kendell, Cynthia, Folkins, Chris, Somayaji, Chandy, Dowden, Jeff, Cheung, Winson, Strumpf, Erin, Beca, Jaclyn M., McClure, Carol, Urquhart, Robin, McDonald, James Ted, Alvi, Riaz, Turner, Donna, Peacock, Stuart, Denburg, Avram, Mercer, Rebecca E., Muñoz, Caroline, Parmar, Ambica, Tadrous, Mina, Takhar, Pam, Chan, Kelvin K. W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8947246/
https://www.ncbi.nlm.nih.gov/pubmed/35323365
http://dx.doi.org/10.3390/curroncol29030165

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8947246/
https://www.ncbi.nlm.nih.gov/pubmed/35323365
http://dx.doi.org/10.3390/curroncol29030165

Ejemplares similares